ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LYEL Lyell Immunopharma Inc

2.61
-0.06 (-2.25%)
May 21 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 36.91M1.25M49.6M1.35M596k317k654k1.09M
Operating Income -37.26M-66.44M-14.78M-62.56M-65.91M-59.04M-59.51M-55.58M
Pre Tax Income -36.32M-70.25M-8.4M-66.96M-63.89M-50.85M-52.93M-60.67M
Net Income -36.32M-70.25M-8.4M-66.96M-63.89M-50.85M-52.93M-60.67M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -37.28M-67.48M-12.9M-61.46M-66.23M-57.46M-60.01M-54.49M
EBITDA -33.09M-61.82M-9.74M-57.53M-60.84M-53.94M-54.45M-50.55M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 657k17.19M12.97M89.44M2.92M
Operating Income -102.09M-211.94M-214.78M-187.06M-247.01M
Pre Tax Income -129.38M-204.47M-250.22M-183.12M-234.63M
Net Income -129.38M-204.47M-250.22M-183.12M-234.63M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -11.571-13.132-1.031-0.734-0.932
EBIT -137.5M-210.41M-214.94M-185.17M-245.16M
EBITDA -100.83M-207.64M-201.28M-169.04M-226.76M